0 of 15 Questions completed
Questions:
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
0 of 15 Questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
What is the primary target of novel anti-malarial agents discussed in this article?
pg 21
Which mechanism is inhibited by compounds with a benzothiazole core scaffold?
pg 22
True or False: Proteasome inhibitors are ineffective in combating malaria.
pg 21
Which stage of the Plasmodium parasite life cycle is influenced by cGMP-dependent protein kinase?
pg 22
What is a key feature of UCT943, the next-generation PI4K inhibitor?
pg 22
True or False: Atovaquone resistance in Plasmodium parasites is linked to mutations in the parasite’s cytochrome b.
pg 21
Which of the following drugs targets malaria parasite histone deacetylases?
pg 23
What is the significance of Plasmodium phosphatidylinositol-4-kinase inhibitors?
pg 24
True or False: Malaria parasites resistant to atovaquone can still transmit via mosquitoes.
pg 23
What mechanism is affected by cytochrome bc1 inhibitors in malaria parasites?
pg 21
What is the potential impact of combining HDAC inhibitors with artemisinin?
pg 24
Which of the following malaria life cycle stages is the focus of PI4K inhibitors?
pg 23
What role does dihydroorotate dehydrogenase play in the malaria parasite?
pg 21
Which strategy is used to prevent malaria transmission by mosquitoes?
pg 22
What is the mechanism of action of proteasome inhibitors in malaria treatment?
pg 21
If you would like to know more about our INRAsafe Accredited Courses please contact us below